Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-06T22:07:16.089Z Has data issue: false hasContentIssue false

Discontinuing MRSA and VRE contact precautions: Defining hospital characteristics and infection prevention practices predicting safe de-escalation

Published online by Cambridge University Press:  01 December 2021

Elise M. Martin*
Affiliation:
Department of Infection Prevention and Control, UPMC Presbyterian, Pittsburgh, Pennsylvania Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Bonnie Colaianne
Affiliation:
Wolff Center, UPMC, Pittsburgh, Pennsylvania
Christine Bridge
Affiliation:
Wolff Center, UPMC, Pittsburgh, Pennsylvania
Andrew Bilderback
Affiliation:
Wolff Center, UPMC, Pittsburgh, Pennsylvania
Colleen Tanner
Affiliation:
Department of Quality, UPMC Passavant, Pittsburgh, Pennsylvania
Suzanne Wagester
Affiliation:
Wolff Center, UPMC, Pittsburgh, Pennsylvania
Mohamed Yassin
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania Department of Infection Prevention and Control, UPMC Mercy, Pittsburgh, Pennsylvania
Raymond Pontzer
Affiliation:
Department of Infection Prevention and Control, UPMC St. Margaret, Pittsburgh, Pennsylvania
Graham M. Snyder
Affiliation:
Department of Infection Prevention and Control, UPMC Presbyterian, Pittsburgh, Pennsylvania Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
*
Author for correspondence: Elise M. Martin, MD, MS, Falk Medical Building, 3601 Fifth Ave, Suite 150, Pittsburgh, PA 15213. E-mail: emm207@pitt.edu
Rights & Permissions [Opens in a new window]

Abstract

Objective:

To define conditions in which contact precautions can be safely discontinued for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).

Design:

Interrupted time series.

Setting:

15 acute-care hospitals.

Participants:

Inpatients.

Intervention:

Contact precautions for endemic MRSA and VRE were discontinued in 12 intervention hospitals and continued at 3 nonintervention hospitals. Rates of MRSA and VRE healthcare-associated infections (HAIs) were collected for 12 months before and after. Trends in HAI rates were analyzed using Poisson regression. To predict conditions when contact precautions may be safely discontinued, selected baseline hospital characteristics and infection prevention practices were correlated with HAI rate changes, stratified by hospital.

Results:

Aggregated HAI rates from intervention hospitals before and after discontinuation of contact precautions were 0.14 and 0.15 MRSA HAI per 1,000 patient days (P = .74), 0.05 and 0.05 VRE HAI per 1,000 patient days (P = .96), and 0.04 and 0.04 MRSA laboratory-identified (LabID) events per 100 admissions (P = .57). No statistically significant rate changes occurred between intervention and non-intervention hospitals. All successful hospitals had low baseline MRSA and VRE HAI rates and high hand hygiene adherence. We observed no correlations between rate changes after discontinuation and the assessed hospital characteristics and infection prevention factors, but the rate improved with higher proportion of semiprivate rooms (P = .04).

Conclusions:

Discontinuing contact precautions for MRSA/VRE did not result in increased HAI rates, suggesting that contact precautions can be safely removed from diverse hospitals, including community hospitals and those with lower proportions of private rooms. Good hand hygiene and low baseline HAI rates may be conditions permissive of safe removal of contact precautions.

Information

Type
Original Article
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1. Hospital Characteristics and Infection Prevention Practices for Intervention and Nonintervention Hospitals

Figure 1

Table 2. Generalized Estimating Equation Poisson Models of the Aggregated MRSA and VRE HAI and LabID Event Rates Before and After Discontinuing Continuing Routine Contact Precautions in the Intervention and Nonintervention Hospitals

Figure 2

Fig. 1. Hospital average monthly MRSA HAI rates, VRE HAI rates, and Lab ID event rates before and after discontinuing continuing routine contact precautions in the intervention and non-intervention hospitals. *P value for change before and after the intervention, 0.021). All other changes in MRSA HAI, VRE HAI, and MRSA lab ID event rates were not statistically significant. Note. MRSA, methicillin-resisitant Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus; LabID, laboratory identified; HAI, hospital-acquired infection; NHSN, National Health Safety Network; MRSA HAI rate = MRSA healthcare associated infections per NHSN per 1,000 patient days; VRE HAI rate = VRE healthcare associated infections per NHSN per 1,000 patient days; MRSA lab ID rate = MRSA lab ID events per NHSN per 100 admissions. Absent bars indicate a rate of zero for that period.

Figure 3

Fig. 2. Aggregated monthly MRSA HAI rates, VRE HAI rates, and LabID event rates before and after discontinuing continuing routine contact precautions in the intervention and non-intervention hospitals. Note. Intervention hospitals: discontinued contact precautions on February 15, 2018, includes aggregated data from hospitals A–L. Nonintervention hospitals: continued contact precautions in the pre and post period, includes aggregated data from hospitals M–O. Note. MRSA, methicillin-resisitant Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus; LabID, laboratory identified; HAI, hospital-acquired infection; NHSN, National Health Safety Network; MRSA HAI rate = MRSA healthcare associated infections per NHSN per 1,000 patient days; VRE HAI rate = VRE healthcare associated infections per NHSN per 1,000 patient days; MRSA lab ID rate = MRSA lab ID events per NHSN per 100 admissions.

Figure 4

Fig. 3. Association between select hospital and infection prevention factors and the change in MRSA and VRE HAI rates in the pre- and post-intervention periods among the 12 intervention hospitals. Note. MRSA, methicillin-resisitant Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus; HAI, healthcare-associated infection; CHG, chlorhexidine gluconate; HH, hand hygiene; UV, ultraviolet light disinfection; ICU, intensive care unit.